Smith, Adam C.
Tsui, Hubert
Usta, Sila
Capo-Chichi, Jose-Mario
Article History
Received: 11 April 2025
Accepted: 18 June 2025
First Online: 8 July 2025
Declarations
:
: Aggregated data that is presented in this study was part of Optical Genome Mapping Validation studies at the University Health Network and was approved by the University Health Network Research Ethics Board (CAPCR# 20-6121).
: Patient consent was waived since the purpose of residual or banked samples being used was for test development (consent waiver part of CACPR# 20-6121).
: ACS has a small personal financial interest in Bionano, Inc (<$1000).